Baird Medical Investment Holdings Limited (BDMD) Stock Analysis & Investment Frameworks
Baird Medical Investment Holdings Limited (BDMD) stock analysis on Invetso. Review Baird Medical Investment Holdings Limited’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Baird Medical Investment Holdings Limited Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: CN
Baird Medical Investment Holdings Limited Key Financial Metrics
- Market Cap: $15.29M
- Revenue: $22.54M
- ROE: -48.23%
- ROIC: -26.96%
- Dividend Yield: N/A
About Baird Medical Investment Holdings Limited
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Baird Medical Investment Holdings Limited Investment Frameworks
Invetso analyzes Baird Medical Investment Holdings Limited (BDMD) across the following frameworks:
- Baird Medical Investment Holdings Limited 10Y Growth Potential
- Baird Medical Investment Holdings Limited Scenario Analysis
- Baird Medical Investment Holdings Limited Risks & Opportunities
- Baird Medical Investment Holdings Limited Economic Moat
- Baird Medical Investment Holdings Limited Business Model
- Baird Medical Investment Holdings Limited Management
- Baird Medical Investment Holdings Limited SWOT Analysis
- Baird Medical Investment Holdings Limited Porter's 5 Forces
- Baird Medical Investment Holdings Limited PESTLE Analysis
- Baird Medical Investment Holdings Limited ESG Analysis